As CPAP treatment was shown to downregulate renin-angiotensin-aldosterone activity [46] and reduce VEGF levels [47] in those without diabetes, these could possibly be mechanistic pathways by which CPAP use is associated with reduced risk of DKD and retinopathy. Here, REN is linked to retinal disorder.